- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (68)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (26)
- Bladder Cancer (72)
- Brain Metastases (28)
- Brain Tumor (230)
- Breast Cancer (720)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (158)
- Colon Cancer (164)
- Colorectal Cancer (114)
- Endocrine Tumor (4)
- Esophageal Cancer (44)
- Eye Cancer (36)
- Fallopian Tube Cancer (8)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (8)
- Kidney Cancer (126)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (100)
- Ovarian Cancer (172)
- Pancreatic Cancer (164)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (238)
- Skin Cancer (296)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (62)
- Testicular Cancer (28)
- Throat Cancer (92)
- Thymoma (6)
- Thyroid Cancer (96)
- Tonsil Cancer (30)
- Uterine Cancer (80)
- Vaginal Cancer (16)
- Vulvar Cancer (20)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (632)
- Complementary Integrative Medicine (24)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (230)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (124)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (118)
- Molecular Diagnostics (8)
- Pain Management (62)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (914)
- Research (398)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (608)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (402)
- Survivorship (322)
- Symptoms (184)
- Treatment (1790)
MD Anderson once again ranked No. 1 cancer hospital
BY Julie Penne
2 minute read | Published August 11, 2016
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on August 11, 2016
MD Anderson again has been ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals” rankings. Since the rankings began in 1990, MD Anderson has been named one of the top two cancer hospitals in the nation and has received the top position nine times in the past 10 years.
“It’s an honor to once again be recognized as the nation’s top hospital for cancer care, which we have earned through our unrelenting passion to serve patients and fulfill our mission to end cancer,” said Ronald DePinho, M.D., president. “We thank our patients and their loved ones who entrust us with their care and salute the 21,000 cancer fighters and 1,000 volunteers who make up our distinctive culture of exceptional care and compassionate caring.”
Two subspecialties also were ranked in the survey’s top 10. In Ear, Nose and Throat, MD Anderson’s Head and Neck Surgery service ranked No. 9. The Gynecologic Oncology and Reproductive Medicine service ranked No. 9 in Gynecology. These subspecialties are especially notable since they include all major general hospitals in the nation, not just cancer centers. Both groups consistently have been high ranked since the early 1990s. Additionally, MD Anderson’s Urology service tied for No. 36 in the national survey.
“This ranking reflects the extraordinary care delivered by our teams of highly subspecialized physicians, outstanding oncology nurses and dedicated supportive care professionals, all working together for the benefit of each patient who comes through our doors,” said Thomas Buchholz, M.D., executive vice president and physician-in-chief.
The institution’s commitment to patients, innovation, mission and outreach are among the hallmarks that have guided its rich 75-year history and that will direct its future. MD Anderson’s diamond anniversary, to be celebrated in November, commemorates the year the Texas Legislature passed a bill to appropriate funding for a state cancer hospital. That same year, the MD Anderson Foundation agreed to match funds if the hospital would be built in Houston. Since that time, more than 1 million patients have sought care at MD Anderson.
“Our ranking as the No. 1 cancer center in our 75th anniversary year is an opportune time to reflect on our global impact. It’s also a time to assure patients and families we are committed to ending this dreaded disease,” said DePinho. “Together, with our patients, survivors, their families and friends, we are Making Cancer History.”
